Monday, 16 January 2012

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

The report provides market landscape, competitive landscape and market trends information on the insulin delivery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Insulin Delivery Devices Market

Published: January 2012
No. of Pages: 104
Price: Single User License – US$3995              Corporate User License – US$11985
                                     

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the insulin delivery devices market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company, Becton, Dickinson and Company and F. Hoffmann-La Roche Ltd.

Explore Comprehensive list of Tables & Figures available in the report @ http://www.reportsnreports.com/reports/144710-insulin-delivery-devices-global-pipeline-analysis-competitive-landscape-and-market-forecasts-to-2017.html.

No comments:

Post a Comment